# Thromboelastography As A Tool for Possible Clopidogrel Resistance in The Patients Treated With Primary PCI for STEMI

> **NCT00517478** · — · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Myocardial Infarction
- Cardiovascular Disease

## Interventions

- **PROCEDURE:** Blood Sample

## Key facts

- **NCT ID:** NCT00517478
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** —
- **Final completion:** 2008-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2007-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517478, "Thromboelastography As A Tool for Possible Clopidogrel Resistance in The Patients Treated With Primary PCI for STEMI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00517478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*